ADT Clinical Trials
7 recruitingDrug
Phase 25Phase 32Phase 12
Showing 1–7 of 7 trials
Recruiting
Phase 3
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Prostate Cancer (Adenocarcinoma)
Canadian Cancer Trials Group830 enrolled340 locationsNCT06592924
Recruiting
Phase 3
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
Prostate Cancer
Canadian Cancer Trials Group710 enrolled57 locationsNCT06235697
Recruiting
Phase 1Phase 2
A Phase I/II Study of PDS01ADC With Docetaxel and Abiraterone in Adults With Metastatic Castration Sensitive and PDS01ADC With Docetaxel in Castration Resistant Prostate Cancer
National Cancer Institute (NCI)86 enrolled1 locationNCT04633252
Recruiting
Phase 2
Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R)
Prostate Cancer
City of Hope Medical Center50 enrolled1 locationNCT07210086
Recruiting
Phase 2
Presurgical Phase II Study of Talazoparib in Combination With Enzalutamide in Prostate Cancer
Prostate Cancer
M.D. Anderson Cancer Center30 enrolled1 locationNCT05873192
Recruiting
Phase 2
Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer
Neoadjuvant Therapy
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School900 enrolled1 locationNCT05406999
Recruiting
Phase 1Phase 2
National Danish Protocol. Surgery+ SBRT for M1 Prostate Cancer Patients
Prostate Cancer Metastatic
Peter Busch Østergren20 enrolled1 locationNCT04086290